A combined risk model shows viability for personalized breast cancer risk assessment in the Indonesian population

Author:

Rabbani Bijak,Tanu Sabrina Gabriel,Ramanto Kevin Nathanael,Audrienna Jessica,Aldila Fatma,Fernandez Eric Aria,Gonzalez-Porta Mar,Valeska Margareta Deidre,Haruman Jessline,Ulag Lorina Handayani,Maulana Yusuf,Junusmin Kathleen IrenaORCID,Amelia Margareta,Gabriella Gabriella,Soetyono Feilicia,Fajarrahman Aulian,Hasan Salma Syahfani Maudina,Agatha Faustina Audrey,Wijaya Marco,Sormin Stevany Tiurma Br,Sani Levana,Ali Soegianto,Irwanto Astrid,Haryono Samuel J

Abstract

AbstractBreast cancer remains a significant concern worldwide, with a rising incidence in Indonesia. This study aims to evaluate the applicability of risk-based screening approaches in the Indonesian demographic through a case-control study involving 305 women. We developed a personalized breast cancer risk assessment workflow that integrates multiple risk factors, including clinical (Gail) and polygenic (Mavaddat) risk predictions, into a consolidated risk category. By evaluating the area under the receiver operating characteristic curve (AUC) of each single-factor risk model, we demonstrate that they retain their predictive accuracy in the Indonesian context (AUC for clinical risk: 0.67 [0.61,0.74]; AUC for genetic risk: 0.67 [0.61,0.73]). Notably, our combined risk approach enhanced the AUC to 0.70 [0.64,0.76], highlighting the advantages of a multifaceted model. Our findings demonstrate for the first time the applicability of the Mavaddat and Gail models to Indonesian populations, and show that within this demographic, combined risk models provide a superior predictive framework compared to single-factor approaches.

Publisher

Cold Spring Harbor Laboratory

Reference48 articles.

1. Current and future burden of breast cancer: Global statistics for 2020 and 2040;The Breast,2022

2. Breast Cancer in Indonesia in 2022: 30 Years of Marching in Place;Indones J Cancer,2022

3. Kemkes. Kanker Payudara Paling Banyak di Indonesia, Kemenkes Targetkan Pemerataan Layanan Kesehatan [Internet]. 2022 [cited 2023 Jul 12]. Available from: https://www.kemkes.go.id/article/view/22020400002/health-care-equality-for-breast-cancer-patients.html

4. American Cancer Society. Understanding a Breast Cancer Diagnosis [Internet]. Survival Rates for Breast Cancer. 2023 [cited 2023 Jul 12]. Available from: https://www.cancer.org/cancer/types/breast-cancer/understanding-a-breast-cancer-diagnosis/breast-cancer-survival-rates.html

5. Breast Cancer Screening: A Summary of the Evidence for the U.S. Preventive Services Task Force

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3